Study | Reason for exclusion |
---|---|
Bostick 1993 | Cohort study: Iowa Women's Health Study cohort Selenium exposure not assessed according to eligibility: only intake of selenium supplements yes/no in questionnaire assessed |
Brock 1991 | Case‐control study with precancerous condition (carcinoma in situ of the cervix) |
Chen 1988 | Case‐control study |
Chen 2003 | Case‐control study |
Connelly‐Frost 2009 | Case‐control study |
Costello 2001 | APPOSE (Australian Prostate Cancer Prevention Trial Using Selenium): publication describes study design, trial was not started |
Criqui 1991 | Population‐based prospective case‐control study: Lipid Research Clinic Prevalence and Follow‐Up study Results not reported according to inclusion criteria: differences in mean selenium levels reported |
Cui 2007 | Nested case‐control study Selenium exposure not assessed according to eligibility: selenium measurement conducted in tissue of benign breast disease |
Davies 2002 | Nested case‐control study: EPIC Norfolk study cohort Results not reported according to inclusion criteria: RR estimate per unit increase in selenium level reported |
Fleshner 2003 | Randomised Study of Vitamin E, Selenium, and Soy Protein Isolate in Patients with High‐Grade Prostatic Intraepithelial Neoplasia: Multicomponent Intervention |
Hagmar 1992 | Historical cohort study |
Harris 2012 | Cancer was not a study endpoint |
Hartman 2002 | Nested case‐control study: ATBC cohort Results not reported according to inclusion criteria: differences in mean selenium levels reported; OR reported as graph and could not be calculated from reported data |
Huzarski 2006 | Interventional study without control group with 1489 female participants with BRCA1 mutation who received a selenium‐containing nutritional supplement |
Joniau 2007 | Intervention study without control group with male participants with high‐grade intraepithelial neoplasia of the prostate who received a selenium‐containing nutritional supplement |
Kellen 2008 | Case‐control study |
Kilander 2001 | Cohort study in Uppsala/Sweden Results not reported according to inclusion criteria: RR estimate per unit increase in selenium level reported |
Knekt 1988a | Nested case‐control study: Mobile Health Clinic cohort Results not reported according to inclusion criteria: differences in mean selenium levels reported |
Knekt 1988b | Nested case‐control study: Mobile Health Clinic cohort Results not reported according to inclusion criteria: differences in mean selenium levels reported |
Knekt 1991 | Nested case‐control study: Mobile Health Clinic cohort Results not reported according to inclusion criteria: differences in mean selenium levels reported |
Kok 1987b | Nested case‐control study: Zoetermeer cohort Results not reported according to inclusion criteria: differences in mean selenium levels reported |
Kune 2006 | Case‐control study |
Kuroda 1988 | Case‐control study |
Lawson 2007 | Cohort study on multivitamin use and risk of prostate cancer |
Le Marchand 2006 | Case‐control study |
Li 2004b | RCT for gastric cancer prevention with multicomponent intervention (200 mg synthetic allitridum and 100 μg selenium per day) |
Limburg 2005 | Randomised controlled trial: primary endpoint in this two‐by‐two factorial design trial with selenomethionine 200 µg daily and/or celecoxib 200 mg twice daily was the per‐participant change (regression, stable, progression) of preexisting oesophageal dysplasia—cancer incidence and mortality were not endpoints in this study |
Linxian Pilot 2000 | Randomised controlled trial with selenium supplements and celecoxib in participants with oesophageal squamous dysplasia in Linxian, China Endpoint was "regression of disease", cancer was not an endpoint in this investigation |
Neuhouser 2009 | Cohort study (Women's Health Initiative) on multivitamin use and risk of cancer and cardiovascular disease No data for selenium and cancer risk reported |
Ray 2006 | Cohort study (Women's Health and Aging Studies I and II) on selenium and carotenoid serum levels and mortality No data for selenium and cancer mortality reported |
Rayman 2001 | PRECISE trial (Prevention of Cancer by Intervention with Selenium): trial has been stopped |
Rendon | Randomised controlled trial: Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients with High‐Grade Prostate Neoplasia: Multicomponent Intervention |
Steevens 2010b | Cancer was not a study endpoint |
Thompson 2009 | Cohort study: Iowa Women's Health Study cohort Selenium exposure not assessed according to eligibility: only intake of selenium supplements yes/no in questionnaire assessed |
Tsugane 1996 | Case‐control and cross‐sectional studies |
Ujiie 2002 | A part of this study is a prospective cohort study in Miyagi/Japan Results not reported according to inclusion criteria: differences in mean selenium levels reported |
van Noord 1992 | Nested case‐control study: DOM cohort Results not reported according to inclusion criteria: differences in mean selenium levels reported |
van Noord 1993 | Nested case‐control study: DOM II cohort Results not reported according to inclusion criteria: RR estimate per unit increase of selenium level reported |
van't Veer 1996 | Case‐control study |
Wallace 2009 | Case‐control study |
Watters 2009 | Cohort study on smoking and prostate cancer risk. Selenium not reported as independent variable |
Wright 2004 | Cohort study: ATBC cohort Exposure to antioxidants was assessed using a self‐developed index |
You 2005 | Randomised controlled trial to test retardation of the progression of precancerous gastric lesions among 3400 adults in Shandong, China. Intervention: vitamin C, vitamin E, selenium, garlic preparation Multicomponent intervention |
Yuan 2006 | Nested case‐control study: Shanghai cohort study No data on selenium and cancer risk reported |
Zeegers 2009 | Cohort study on factors influencing recurrence or progression of bladder cancer: West Midlands Bladder Cancer Prognosis Programme |
µ = micro
APPOSE = Australian Prostate Cancer Prevention Trial Using Selenium ATBC = alpha‐tocopherol, beta‐carotene cancer prevention study BRCA = breast cancer DOM = Diagnostic Onderzoek Mammacarcinoom EPIC = European Prospective Investigation of Cancer m = milli g = gram
OR = odds ratio PRECISE = Prevention of Cancer by Intervention with Selenium RCT = randomised controlled trial